Atropine drops for drooling: A randomized controlled trial

Palliative Medicine

Volumn 20, Issue 7, 2006, Pages 665-671

  De Simone, Gustavo ^a   Eisenchlas, Jorge H ^a   Junin, Marta ^a   Pereyra, Facundo ^a   Brizuela, Rafael ^a  

^a HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

Author keywords

Advanced cancer; Atropine; Drooling; Palliative care

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ATROPINE; DEXAMETHASONE; LEVOMEPROMAZINE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLACEBO;

ADULT; ADVANCED CANCER; AGED; AIRWAY OBSTRUCTION; ANALYSIS OF VARIANCE; ARGENTINA; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAILY LIFE ACTIVITY; DIGESTIVE SYSTEM CANCER; DOUBLE BLIND PROCEDURE; DRUG CHOICE; DRUG EFFICACY; FEMALE; HUMAN; HYPERSALIVATION; MALE; OUTCOMES RESEARCH; PATIENT DECISION MAKING; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOCIAL INTERACTION; UPPER GASTROINTESTINAL TRACT; VISUAL ANALOG SCALE; XEROSTOMIA;

ADMINISTRATION, SUBLINGUAL; AGED; AGED, 80 AND OVER; ATROPINE; CROSS-OVER STUDIES; DIGESTIVE SYSTEM NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; SIALORRHEA; TREATMENT OUTCOME;

EID: 33751250806     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216306071702     Document Type: Article

References (30)

1. Lucas V, Schofield L. Treatment of drooling. Eur J Palliat Care 2000; 7: 5-7.
2. Ventafridda V, Ripamonte C, Sbanotto A, De Conno F. Mouth care. In Doyle D et al. eds. Oxford textbook of palliative medicine, second edition. Oxford University Press, 1998: 701-702.
3. Zepetella G. Nebulized scopolamine in the management of oral dribbling: three case reports. J Pain Symptom Manage 1999; 17: 293-95.
4. Tahmassebi J, Curzon M. The cause of drooling in children with cerebral palsy - hypersalivation or swallowing defect? Int J Paediatr Dent 2003; 13: 106-11.
5. Boyce HW, Bakheet MR. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol 2005; 39: 89-97.
6. Rashid H, Long J, Wadleigh R. Management of secretions in esophageal cancer patients with glycopyrrolate. Ann Oncol 1997; 8: 198-99.
7. Jobbins J, Bagg J, Finlay IG, Addy M, Newcombe RG. Oral and dental disease in terminally ill cancer patients. Br Med J 1992; 304: 1612.
8. Twycross R, Wilcock A. Symptom management in advanced cancer, third edition. Radcliffe Medical Press, 2001.
9. Bausewein C. Comparative cost of hyoscine injections. Palliat Med 1995; 9: 256.
10. Finkelstein DM, Crysdale WS. Evaluation and management of the drooling patient. J Otolaryngol 1992; 21: 414-18.
11. Crysdale WS, McCann C, Roske L, Joseph M, Semenuk D, Chait P. Saliva control issues in the neurologically challenged. A 30 year experience in team management. Int J Pediatr Otorhinolaryngol 2005; 70: 519-27.
12. Borg M. Radiotherapy for the management of hypersalivation. J Paediatr Child Health 1977; 33: 52-54.
13. Borg M, Hirst F. The role of radiation therapy in the management of sialorrhea. Int J Radiat Oncol Biol Phys 1998; 41: 1113-19.
14. Lewis DW, Fontana C, Mehallick LK, Everett Y. Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol 1994; 36: 484-86.
15. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 1989; 31: 309-19.
16. Doyle J, Walker P, Bruera E. Nebulized scopolamine. J Pain Symptom Manage 2000; 19: 327-28.
17. Tassinari D, Poggi B, Fantini M, Tamburini E, Sartori S. Treating sialorrhea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients. Support Care Cancer 2005; 13: 559-61.
18. Olsen A, Sjogren P. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer. J Pain Symptom Manage 1999; 18: 300-302.
19. Volz-Zang C, Waldhauser T, Schulte B, Palm D. Comparison of the effects of atropine in vivo and ex vivo (radioreceptor assay) after oral and intramuscular administration to man. Eur J Clin Pharmacol 1995; 49: 45-49.
20. Hyson CH, Johnson A, Jog M. Sublingual atropine for sialorrhea secondary to Parkinsonism: a pilot study. Move Disord 2002; 17: 1318-20.
21. Comley C, Galletly C, Ash D. Use of atropine eye drops for clozapine induced hypersalivation. Aus NZ J Psychiatry 2000; 34: 1033-34.
22. Twycross R, Wilcock A, Charlesworth S, Dickman A. Palliative care formulary, second edition. Radcliffe Medical Press, 2002.
23. Jongerius PH, van Tiel P, van Limbeek J, Gabreëls F, Rotteveel J. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Childhood 2003; 88: 911-14.
24. Pal PK, Calne DB, Calne S, Tsui JK. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000; 54: 244-47.
25. Pai S, Ghezzi EM, Ship JA. Development of a visual analogue scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg Oral Med Oral Pathol Radiol Endosc 2001; 3: 311-16.
26. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a 'trial effect'. J Clin Epidemiol 2001; 54: 217-24.
27. Morton V, Torgerson D. Effect of regression to the mean on decision making in health care. BMJ 2003; 326: 1083-84.
28. Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK. The impact of disease severity on the informed consent process in clinical research. Am J Med 1996; 100: 261-68.
29. Eisenchlas J. The oncology/palliative care interphase. UWCM Palliative Medicine Diploma Course, July 2002.
30. Al-Memar AY, Roy D, Powel A, Pall HS. Treatment with atropine sulphate 1% drops in the management of bulbar MND. J Neurol Neurosurg Psychiatry 1998; 64: 704.